Novonix Stock Fundamentals
| NVNXF Stock | USD 0.48 0.03 5.88% |
Novonix fundamentals help investors to digest information that contributes to Novonix's financial success or failures. It also enables traders to predict the movement of Novonix Pink Sheet. The fundamental analysis module provides a way to measure Novonix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Novonix pink sheet.
Novonix |
Novonix Company Return On Equity Analysis
Novonix's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Novonix Return On Equity | -0.26 |
Most of Novonix's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Novonix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Novonix has a Return On Equity of -0.2604. This is 159.18% lower than that of the Industrials sector and significantly lower than that of the Electrical Equipment & Parts industry. The return on equity for all United States stocks is 16.0% lower than that of the firm.
Novonix Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Novonix's current stock value. Our valuation model uses many indicators to compare Novonix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Novonix competition to find correlations between indicators driving Novonix's intrinsic value. More Info.Novonix is regarded third in return on equity category among its peers. It is regarded second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Novonix's earnings, one of the primary drivers of an investment's value.Novonix Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Novonix's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Novonix could also be used in its relative valuation, which is a method of valuing Novonix by comparing valuation metrics of similar companies.Novonix is currently under evaluation in return on equity category among its peers.
Novonix Fundamentals
| Return On Equity | -0.26 | |||
| Return On Asset | -0.12 | |||
| Operating Margin | (7.36) % | |||
| Current Valuation | 534.72 M | |||
| Shares Outstanding | 485.95 M | |||
| Shares Owned By Insiders | 28.18 % | |||
| Shares Owned By Institutions | 10.90 % | |||
| Price To Book | 2.49 X | |||
| Price To Sales | 69.85 X | |||
| Revenue | 8.42 M | |||
| Gross Profit | 5.41 M | |||
| EBITDA | (63.54 M) | |||
| Net Income | (71.44 M) | |||
| Cash And Equivalents | 207.08 M | |||
| Cash Per Share | 0.43 X | |||
| Total Debt | 52.15 M | |||
| Debt To Equity | 0.17 % | |||
| Current Ratio | 20.56 X | |||
| Book Value Per Share | 0.75 X | |||
| Cash Flow From Operations | (40.35 M) | |||
| Earnings Per Share | (0.06) X | |||
| Beta | 1.73 | |||
| Market Capitalization | 536.98 M | |||
| Total Asset | 439.56 M | |||
| Z Score | 6.0 | |||
| Net Asset | 439.56 M |
About Novonix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Novonix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Novonix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Novonix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Novonix Limited develops and supplies battery materials, equipment, and services to the lithium-ion battery market in North America. Novonix Limited was incorporated in 2012 and is based in Brisbane, Australia. Novonix is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Novonix Pink Sheet
Novonix financial ratios help investors to determine whether Novonix Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Novonix with respect to the benefits of owning Novonix security.